Melanoma staging: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
Sergekorjian (talk | contribs) |
||
Line 77: | Line 77: | ||
'''Stage I/II''': Invasive Melanoma, 85-95% Survival | '''Stage I/II''': Invasive Melanoma, 85-95% Survival | ||
*T1a: | *T1a: Clark Level II-III | ||
*T1b: | *T1b: Clark Level IV-V | ||
*T2a | *T2a | ||
'''Stage II''': High Risk Melanoma, 40-85% Survival | '''Stage II''': High Risk Melanoma, 40-85% Survival | ||
*T2b | *T2b | ||
*T3a | *T3a | ||
*T3b | *T3b | ||
*T4a | *T4a | ||
*T4b | *T4b | ||
'''Stage III''': Regional Metastasis, 25-60% Survival | '''Stage III''': Regional Metastasis, 25-60% Survival | ||
*N1 | *N1 | ||
*N2 | *N2 | ||
*N3 | *N3 | ||
'''Stage IV''': Distant Metastasis, 9-15% Survival | '''Stage IV''': Distant Metastasis, 9-15% Survival | ||
*M1a | *M1a | ||
*M1b | *M1b | ||
*M1c | *M1c | ||
''Based Upon AJCC 5-Year Survival With Proper Treatment'' | ''Based Upon AJCC 5-Year Survival With Proper Treatment'' |
Revision as of 21:00, 21 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Melanoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Melanoma staging On the Web |
American Roentgen Ray Society Images of Melanoma staging |
Overview
Staging
2010 American Joint Committee on Cancer (AJC) TNM Definitions for Melanoma
Primary Tumor (T)
T Classification | Thickness | Ulceration status/mitoses |
TX | Primary tumor cannot be assessed | |
T0 | No evidence of primary tumor | |
Tis | Melanoma in situ | |
T1b | ≤ 1.0 mm | Ulcerated or ≥1 mitosis/mm2 |
T2a | 1.01 - 2.0 mm | No ulceration |
T2b | 1.01 - 2.0 mm | Ulcerated |
T3a | 2.01 - 4.0 mm | No ulceration |
T3b | 2.01 - 4.0 mm | Ulcerated |
T4a | > 4.0 mm | No ulceration |
T4b | > 4.0 mm | Ulcerated |
Regional Lymph Nodes (N)
N Classification | Number of Nodes | Nodal Mass |
NX | Lymph node metastasis cannot be assessed | |
N0 | No lymph node metastasis | |
N1a | 1 node | Micrometastasis |
N1b | 1 node | Macrometastasis |
N2a | 2 - 3 nodes | Micrometastasis |
N2b | 2 - 3 nodes | Macrometastasis |
N2c | 2 - 3 nodes | In-transit metastasis/Satellites without metastatic nodes |
N3 | ≥ 4 nodes | Metastatic nodes, Matted nodes, In-transit metastasis/Satellites with metastatic nodes |
Distant Metastasis (M)
M Classification | Definition |
M0 | No evidence of distant metastasis |
M1a | Metastasis to skin, subcutaneous tissue, or distant lymph nodes |
M1b | Metasitasis to lung |
M1c | Metastasis to any other visceral site with elevated LDH |
Also of importance are the "Clark level" and "Breslow depth" which refer to the microscopic depth of tumor invasion.[1]
Staging of Melanoma
Stage 0: Melanoma in Situ (Clark Level I), 100% Survival
Stage I/II: Invasive Melanoma, 85-95% Survival
- T1a: Clark Level II-III
- T1b: Clark Level IV-V
- T2a
Stage II: High Risk Melanoma, 40-85% Survival
- T2b
- T3a
- T3b
- T4a
- T4b
Stage III: Regional Metastasis, 25-60% Survival
- N1
- N2
- N3
Stage IV: Distant Metastasis, 9-15% Survival
- M1a
- M1b
- M1c
Based Upon AJCC 5-Year Survival With Proper Treatment
References
- ↑ Malignant melanoma: staging at Collaborative Hypertext of Radiology